PTPRε通过促进SMAD3募集至TGF-β受体1促进肝细胞癌转移
该研究探讨TGF-β/SMAD3信号及下游效应分子在肝细胞癌(HCC)迁移和转移中的作用。体外和体内实验表明SMAD3和PTPRε促进HCC细胞迁移、侵袭和转移;TGF-β刺激后SMAD3直接结合PTPRε启动子激活其表达,PTPRε与TGFBR1/SMAD3相互作用并促进SMAD3募集至TGFBR1,维持SMAD3持续活化。HCC样本中pSMAD3/SMAD3与PTPRε表达正相关,SMAD3或PTPRε高表达与患者不良预后相关。结论:PTPRε正反馈调节TGF-β/SMAD3信号促进HCC转移。
要点
- SMAD3和PTPRε在体外和体内促进HCC细胞迁移、侵袭和转移。
- TGF-β刺激后SMAD3直接结合PTPRε启动子激活其表达。
- PTPRε与TGFBR1/SMAD3相互作用,促进SMAD3募集至TGFBR1并维持其持续活化。
核心结论
- PTPRε正反馈调节TGF-β/SMAD3信号,促进肝细胞癌转移。
研究设计与样本
- 采用体外Trans-well迁移和侵袭实验及体内转移模型研究HCC细胞迁移、侵袭和转移。
- 在HCC样本中分析pSMAD3/SMAD3与PTPRε表达的相关性及其与预后的关系。
主要发现
- SMAD3和PTPRε促进HCC细胞体外迁移、侵袭及体内转移。
- TGF-β刺激后SMAD3直接结合PTPRε启动子激活其表达。
- PTPRε与TGFBR1/SMAD3相互作用,促进SMAD3募集至TGFBR1,导致SMAD3持续活化。
- PTPRε的酪氨酸磷酸酶活性对其与TGFBR1结合、SMAD3募集和活化及体外促转移作用重要。
- HCC样本中pSMAD3/SMAD3与PTPRε表达正相关,SMAD3或PTPRε高表达与患者不良预后相关。
临床怎么用
- SMAD3或PTPRε高表达与HCC患者不良预后相关,可能作为预后评估的参考指标。
- PTPRε正反馈调节TGF-β/SMAD3信号促进HCC转移,可能为HCC转移防治提供潜在靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Transforming growth factor beta (TGF-β) suppresses early stages of tumorigenesis, but contributes to the migration and metastasis of cancer cells. However, the role of TGF-β signaling in invasive prometastatic hepatocellular carcinoma (HCC) is poorly understood. In this study, we investigated the roles of canonical TGF-β/mothers against decapentaplegic homolog 3 (SMAD3) signaling and identified downstream effectors on HCC migration and metastasis. APPROACH AND RESULTS: By using in vitro trans-well migration and invasion assays and in vivo metastasis models, we demonstrated that SMAD3 and protein tyrosine phosphatase receptor epsilon (PTPRε) promote migration, invasion, and metastasis of HCC cells in vitro and in vivo. Further mechanistic studies revealed that, following TGF-β stimulation, SMAD3 binds directly to PTPRε promoters to activate its expression. PTPRε interacts with TGFBR1/SMAD3 and facilitates recruitment of SMAD3 to TGFBR1, resulting in a sustained SMAD3 activation status. The tyrosine phosphatase activity of PTPRε is important for binding with TGFBR1, recruitment and activation of SMAD3, and its prometastatic role in vitro. A positive correlation between pSMAD3/SMAD3 and PTPRε expression was determined in HCC samples, and high expression of SMAD3 or PTPRε was associated with poor prognosis of patients with HCC. CONCLUSIONS: PTPRε positive feedback regulates TGF-β/SMAD3 signaling to promote HCC metastasis.
引用
- Liao Z, Chen L, Zhang X, et al. PTPRε Acts as a Metastatic Promoter in Hepatocellular Carcinoma by Facilitating Recruitment of SMAD3 to TGF-β Receptor 1. Hepatology. 2020. PMID: 31903610. doi:10.1002/hep.31104
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。